Alzheimer's drug Leqembi gets full FDA approval. Medicare coverage will likely follow

The first drug found to slow the progression of Alzheimer's disease has been granted full approval by the Food and Drug Administration.

Related Keywords

Missouri ,United States ,Japan ,Japanese ,Susan Bell ,Sanjeev Vaishnavi ,Joanne Pike ,Medicaid Services ,Centers For Medicare ,Drug Administration ,Leqembi At Washington University In St ,Alzheimer Association ,Penn Memory Center ,Penn Memory ,Washington University ,